Diabetes Mellitus, ArterialWall, and Cardiovascular Risk Assessment.

PubWeight™: 0.81‹?›

🔗 View Article (PMID 26861377)

Published in Int J Environ Res Public Health on February 06, 2016

Authors

Michaela Kozakova1, Carlo Palombo2

Author Affiliations

1: Department of Clinical and Experimental Medicine, University of Pisa, Pisa 56122, Italy. m.kozakova@int.med.unipi.it.
2: Department of Surgical, Medical, Molecular Pathology and Critical Care Medicine, University of Pisa, Pisa 56122, Italy. carlo.palombo@unipi.it.

Articles cited by this

(truncated to the top 100)

10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med (2008) 35.49

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ (2000) 35.06

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. BMJ (1998) 32.73

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. Lancet (1998) 26.64

Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med (2003) 20.06

2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens (2013) 18.17

Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther (2001) 14.78

Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA (2006) 11.78

Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA (2002) 8.81

Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force. Endorsed by the Society for Vascular Medicine. J Am Soc Echocardiogr (2008) 7.91

Diabetes, oxidative stress, and antioxidants: a review. J Biochem Mol Toxicol (2003) 6.78

Relation between age and cardiovascular disease in men and women with diabetes compared with non-diabetic people: a population-based retrospective cohort study. Lancet (2006) 6.64

Endothelial function and dysfunction: testing and clinical relevance. Circulation (2007) 6.47

Aortic pulse-wave velocity and its relationship to mortality in diabetes and glucose intolerance: an integrated index of vascular function? Circulation (2002) 6.22

Role of endothelial dysfunction in atherosclerosis. Circulation (2004) 5.77

Diabetes and cardiovascular risk factors: the Framingham study. Circulation (1979) 5.32

Determinants of pulse wave velocity in healthy people and in the presence of cardiovascular risk factors: 'establishing normal and reference values'. Eur Heart J (2010) 5.02

Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance. J Clin Invest (1996) 4.98

Aortic pulse wave velocity improves cardiovascular event prediction: an individual participant meta-analysis of prospective observational data from 17,635 subjects. J Am Coll Cardiol (2013) 3.89

Insulin sensitivity and atherosclerosis. The Insulin Resistance Atherosclerosis Study (IRAS) Investigators. Circulation (1996) 3.88

Efficacy of lipid lowering drug treatment for diabetic and non-diabetic patients: meta-analysis of randomised controlled trials. BMJ (2006) 3.68

Arterial aging: is it an immutable cardiovascular risk factor? Hypertension (2005) 3.55

Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: the missing links. The Claude Bernard Lecture 2009. Diabetologia (2010) 3.17

Mannheim carotid intima-media thickness and plaque consensus (2004-2006-2011). An update on behalf of the advisory board of the 3rd, 4th and 5th watching the risk symposia, at the 13th, 15th and 20th European Stroke Conferences, Mannheim, Germany, 2004, Brussels, Belgium, 2006, and Hamburg, Germany, 2011. Cerebrovasc Dis (2012) 3.11

Homeostasis model assessment of insulin resistance in relation to the incidence of cardiovascular disease: the San Antonio Heart Study. Diabetes Care (2002) 2.92

Intensive glycemic control in the ACCORD and ADVANCE trials. N Engl J Med (2008) 2.79

Endothelium-derived nitric oxide regulates arterial elasticity in human arteries in vivo. Hypertension (2001) 2.69

Increased pulse wave velocity is not associated with elevated augmentation index in patients with diabetes. J Hypertens (2004) 2.50

Insulin resistance, hyperglycemia, and atherosclerosis. Cell Metab (2011) 2.47

Reduction of oxidative stress and inflammation by blunting daily acute glucose fluctuations in patients with type 2 diabetes: role of dipeptidyl peptidase-IV inhibition. Diabetes Care (2012) 2.43

Arterial stiffness in diabetes and the metabolic syndrome: a pathway to cardiovascular disease. Diabetologia (2008) 2.26

Microvascular and macrovascular reactivity is reduced in subjects at risk for type 2 diabetes. Diabetes (1999) 2.21

Insulin resistance as estimated by homeostasis model assessment predicts incident symptomatic cardiovascular disease in caucasian subjects from the general population: the Bruneck study. Diabetes Care (2007) 2.03

Increased central artery stiffness in impaired glucose metabolism and type 2 diabetes: the Hoorn Study. Hypertension (2003) 2.00

Local stiffness of the carotid and femoral artery is associated with incident cardiovascular events and all-cause mortality: the Hoorn study. J Am Coll Cardiol (2014) 1.91

Insulin resistance and atherosclerosis. Endocr Rev (2006) 1.81

Relation of carotid artery wall thickness to diabetes mellitus, fasting glucose and insulin, body size, and physical activity. Atherosclerosis Risk in Communities (ARIC) Study Investigators. Stroke (1994) 1.71

Segment-specific associations of carotid intima-media thickness with cardiovascular risk factors: the Coronary Artery Risk Development in Young Adults (CARDIA) study. Stroke (2009) 1.70

Insulin resistance and endothelial dysfunction: the road map to cardiovascular diseases. Diabetes Metab Res Rev (2006) 1.66

Risk factors that attenuate the female coronary disease advantage. Arch Intern Med (1995) 1.59

Endothelial dysfunction is detectable in young normotensive first-degree relatives of subjects with type 2 diabetes in association with insulin resistance. Circulation (2000) 1.59

Relation between insulin resistance and carotid intima-media thickness and stenosis in non-diabetic subjects. Results from a cross-sectional study in Malmö, Sweden. Diabet Med (2000) 1.58

Glycosylated hemoglobin in relationship to cardiovascular outcomes and death in patients with type 2 diabetes: a systematic review and meta-analysis. PLoS One (2012) 1.57

Carotid and aortic stiffness: determinants of discrepancies. Hypertension (2006) 1.56

Methods for evaluating endothelial function: a position statement from the European Society of Cardiology Working Group on Peripheral Circulation. Eur J Cardiovasc Prev Rehabil (2011) 1.55

Insulin resistance as a risk factor for carotid atherosclerosis: a comparison of the Homeostasis Model Assessment and the short insulin tolerance test. Stroke (2008) 1.55

Non-insulin-dependent diabetes mellitus and fasting glucose and insulin concentrations are associated with arterial stiffness indexes. The ARIC Study. Atherosclerosis Risk in Communities Study. Circulation (1995) 1.54

Should diabetes be considered a coronary heart disease risk equivalent?: results from 25 years of follow-up in the Renfrew and Paisley survey. Diabetes Care (2005) 1.52

Carotid artery intima-media thickness in patients with Type 2 diabetes mellitus and impaired glucose tolerance: a systematic review. Diabet Med (2006) 1.43

The role of vascular biomarkers for primary and secondary prevention. A position paper from the European Society of Cardiology Working Group on peripheral circulation: Endorsed by the Association for Research into Arterial Structure and Physiology (ARTERY) Society. Atherosclerosis (2015) 1.37

Repetitive fluctuations in blood glucose enhance monocyte adhesion to the endothelium of rat thoracic aorta. Arterioscler Thromb Vasc Biol (2006) 1.35

Elevated C-reactive protein associates with early-stage carotid atherosclerosis in young subjects with type 1 diabetes. Diabetes Care (2002) 1.32

The relationship between endothelial dysfunction and oxidative stress in diabetes and prediabetes. Int J Clin Pract (2008) 1.32

Molecular basis of arterial stiffening: role of glycation - a mini-review. Gerontology (2012) 1.26

The aging of elastic and muscular arteries: a comparison of diabetic and nondiabetic subjects. Diabetes Care (2003) 1.26

Obesity in youth is not an independent predictor of carotid IMT in adulthood. The Cardiovascular Risk in Young Finns Study. Atherosclerosis (2005) 1.25

High glucose alters matrix metalloproteinase expression in two key vascular cells: potential impact on atherosclerosis in diabetes. Atherosclerosis (2003) 1.24

Effects of systemic inflammation on endothelium-dependent vasodilation. Trends Cardiovasc Med (2006) 1.24

Increased arterial stiffness in healthy subjects with high-normal glucose levels and in subjects with pre-diabetes. Cardiovasc Diabetol (2011) 1.23

Advanced glycation end products and endothelial dysfunction in type 2 diabetes. Diabetes Care (2002) 1.22

Reference intervals for common carotid intima-media thickness measured with echotracking: relation with risk factors. Eur Heart J (2012) 1.21

Relationship between fluctuations in glucose levels measured by continuous glucose monitoring and vascular endothelial dysfunction in type 2 diabetes mellitus. Cardiovasc Diabetol (2013) 1.18

3D ultrasound measurement of change in carotid plaque volume: a tool for rapid evaluation of new therapies. Stroke (2005) 1.17

Local pulse pressure and regression of arterial wall hypertrophy during long-term antihypertensive treatment. Circulation (2000) 1.16

Insulin resistance in the vasculature. J Clin Invest (2013) 1.16

Insulin sensitivity, proinsulin and insulin as predictors of coronary heart disease. A population-based 10-year, follow-up study in 70-year old men using the euglycaemic insulin clamp. Diabetologia (2005) 1.15

Impact of metabolic indices on central artery stiffness: independent association of insulin resistance and glucose with aortic pulse wave velocity. Diabetologia (2010) 1.15

Hemoglobin A1c levels and aortic arterial stiffness: the Cardiometabolic Risk in Chinese (CRC) study. PLoS One (2012) 1.14

Impaired endothelium-dependent and independent dilatation of forearm resistance arteries in men with diet-treated non-insulin-dependent diabetes: role of dyslipidaemia. Clin Sci (Lond) (1996) 1.12

Sex differences in age-related stiffening of the aorta in subjects with type 2 diabetes. Hypertension (2004) 1.11

In vivo endothelial dysfunction characterizes patients with impaired fasting glucose. Diabetes Care (1999) 1.09

Influence of duration of diabetes, glycemic control, and traditional cardiovascular risk factors on early atherosclerotic vascular changes in adolescents and young adults with type 2 diabetes mellitus. J Clin Endocrinol Metab (2009) 1.09

Mechanism of high glucose induced angiotensin II production in rat vascular smooth muscle cells. Circ Res (2007) 1.09

Duration of diabetes and carotid wall thickness. The Insulin Resistance Atherosclerosis Study (IRAS). Stroke (1997) 1.08

Effect of insulin on growth of cultured human arterial smooth muscle cells. Diabetologia (1981) 1.06

A comparison of ultrasound measurements to assess carotid atherosclerosis development in subjects with and without type 2 diabetes. Cardiovasc Ultrasound (2005) 1.02

Nitric oxide synthesis is reduced in subjects with type 2 diabetes and nephropathy. Diabetes (2010) 1.02

Adiponectin and carotid intima-media thickness in the northern Manhattan study. Stroke (2011) 1.02

Stiffness indexes beta of the common carotid and femoral arteries are associated with insulin resistance in NIDDM. Diabetes Care (1998) 0.99

Influence of hypertension on early carotid artery remodeling. Arterioscler Thromb Vasc Biol (2003) 0.97

Impaired endothelium-dependent vasodilation in type 2 diabetes. Relation to LDL size, oxidized LDL, and antioxidants. Diabetes Care (1999) 0.97

Carotid arterial remodeling: a maladaptive phenomenon in type 2 diabetes but not in impaired glucose metabolism: the Hoorn study. Stroke (2004) 0.95

Fatty acids acutely enhance insulin-induced oxidative stress and cause insulin resistance by increasing mitochondrial reactive oxygen species (ROS) generation and nuclear factor-κB inhibitor (IκB)-nuclear factor-κB (NFκB) activation in rat muscle, in the absence of mitochondrial dysfunction. Diabetologia (2011) 0.93

Central pulse pressure and its hemodynamic determinants in middle-aged adults with impaired fasting glucose and diabetes: the Asklepios study. Diabetes Care (2013) 0.92

Body composition and common carotid artery remodeling in a healthy population. J Clin Endocrinol Metab (2008) 0.90

Correlation between glucose fluctuations and carotid intima-media thickness in type 2 diabetes. Diabetes Res Clin Pract (2010) 0.89

Associations between blood glucose and carotid intima-media thickness disappear after adjustment for shared risk factors: the KORA F4 study. PLoS One (2012) 0.89

Arterial stiffness is strongly associated with insulin resistance in Chinese--a population-based study (Taichung Community Health Study, TCHS). J Atheroscler Thromb (2010) 0.89

Hyperglycemia and arterial stiffness: the Atherosclerosis Risk in the Communities study. Atherosclerosis (2012) 0.87

Elevated 1-h plasma glucose following 75-g oral glucose load is a predictor of arterial stiffness in subjects with normal glucose tolerance. Diabet Med (2012) 0.87

Pathogenesis of atherosclerosis in diabetes mellitus. Diabetes Care (1981) 0.86

Pulse pressure and subclinical cardiovascular disease in the multi-ethnic study of atherosclerosis. Am J Hypertens (2013) 0.86

Chronic physiologic hyperinsulinemia impairs suppression of plasma free fatty acids and increases de novo lipogenesis but does not cause dyslipidemia in conscious normal rats. Metabolism (1999) 0.85

Stimulatory effect of insulin on aortic smooth muscle cell migration induced by 12-L-hydroxy-5,8,10,14-eicosatetraenoic acid and its modulation by elevated extracellular glucose levels. Diabetes (1985) 0.84

Glucose-related arterial stiffness and carotid artery remodeling: a study in normal subjects and type 2 diabetes patients. J Clin Endocrinol Metab (2014) 0.84

Carotid atherosclerosis severity in relation to glycemic status: a cross-sectional population study. Atherosclerosis (2015) 0.84

Reference values for local arterial stiffness. Part A: carotid artery. J Hypertens (2015) 0.83

Arterial stiffness and coronary artery disease. Curr Opin Cardiol (2015) 0.83

Free fatty acids are associated with obesity, insulin resistance, and atherosclerosis in renal transplant recipients. Transplantation (2005) 0.83

Glycated hemoglobin as a marker of subclinical atherosclerosis and cardiac remodeling among non-diabetic adults from the general population. Diabetes Res Clin Pract (2014) 0.83